These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 8390433

  • 21. The in-vitro activity of CP 99,219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents.
    Child J, Andrews J, Boswell F, Brenwald N, Wise R.
    J Antimicrob Chemother; 1995 Jun; 35(6):869-76. PubMed ID: 7559198
    [Abstract] [Full Text] [Related]

  • 22. In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae.
    Roblin PM, Montalban G, Hammerschlag MR.
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1402-3. PubMed ID: 8092845
    [Abstract] [Full Text] [Related]

  • 23. Antimicrobial activity of CS-940, a new trifluorinated quinolone.
    Biedenbach DJ, Sutton LD, Jones RN.
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2325-30. PubMed ID: 8619590
    [Abstract] [Full Text] [Related]

  • 24. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA, Tayeb OS.
    Microbios; 1993 Oct; 74(300):147-54. PubMed ID: 8396196
    [Abstract] [Full Text] [Related]

  • 25. Antibacterial activity of a new tetracyclic quinolone, No. 5290, against norfloxacin- and ciprofloxacin-resistant strains of Staphylococcus aureus.
    Kotera Y, Inoue Y, Ohashi M, Ito K, Tsukamoto G.
    Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2644-6. PubMed ID: 1666861
    [Abstract] [Full Text] [Related]

  • 26. Plasma bactericidal activity of a new C-5 methyl fluoroquinolone after oral doses of 400 and 800 mg.
    Gu JW, Fang W, Neu HC.
    J Clin Pharmacol; 1992 Sep; 32(9):804-7. PubMed ID: 1331205
    [Abstract] [Full Text] [Related]

  • 27. In vitro activity of E-4868, a new trifluoroquinolone, compared to six similar compounds.
    Barrett MS, Jones RN, Erwin ME.
    Eur J Clin Microbiol Infect Dis; 1993 Feb; 12(2):134-41. PubMed ID: 8388792
    [Abstract] [Full Text] [Related]

  • 28. The comparative in-vitro activity of pefloxacin.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213
    [Abstract] [Full Text] [Related]

  • 29. The in-vitro activity of PD127,391, a new quinolone.
    King A, Boothman C, Phillips I.
    J Antimicrob Chemother; 1988 Aug; 22(2):135-41. PubMed ID: 3182416
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of OPC-17116 against important pathogens that cause respiratory tract infections.
    Wakebe H, Imada T, Yoneda H, Mukai F, Ohguro K, Ohmori K, Tamaoka H, Yabuuchi Y.
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2340-5. PubMed ID: 7840567
    [Abstract] [Full Text] [Related]

  • 31. In vitro activity of DU-6859a, a new fluorocyclopropyl quinolone.
    Marshall SA, Jones RN.
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2747-53. PubMed ID: 8109948
    [Abstract] [Full Text] [Related]

  • 32. In vitro comparison activity of OPC-17116, a new fluoroquinolone, against more than 5,000 recent clinical isolates from five medical centers.
    Sader HS, Jones RN, Allen SD, Gerlach EH, Murray PR, Washington JA.
    J Chemother; 1993 Oct; 5(5):283-8. PubMed ID: 8106899
    [Abstract] [Full Text] [Related]

  • 33. In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp.
    Miyashita N, Niki Y, Kishimoto T, Nakajima M, Matsushima T.
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1331-4. PubMed ID: 9174194
    [Abstract] [Full Text] [Related]

  • 34. Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.
    Bauernfeind A.
    J Antimicrob Chemother; 1993 Apr; 31(4):505-22. PubMed ID: 7605398
    [Abstract] [Full Text] [Related]

  • 35. Dissociated resistance among fluoroquinolones.
    Thomson KS, Sanders CC.
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2095-100. PubMed ID: 7811025
    [Abstract] [Full Text] [Related]

  • 36. Antibacterial activities of OPC-17116, ofloxacin, and ciprofloxacin against 200 isolates of Neisseria gonorrhoeae.
    Zenilman JM, Neumann T, Patton M, Reichart C.
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2244-6. PubMed ID: 8257153
    [Abstract] [Full Text] [Related]

  • 37. In vitro activity of lomefloxacin (SC 47111 or NY-198) against Chlamydia trachomatis strains.
    Segreti J, Kessler HA, Kapell K, Trenholme GM.
    Diagn Microbiol Infect Dis; 1989 Oct; 12(3 Suppl):87S-88S. PubMed ID: 2791503
    [Abstract] [Full Text] [Related]

  • 38. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
    McCarter YS, Mazens-Sullivan MF, Bartlett RC.
    Chemotherapy; 1992 Oct; 38(5):308-18. PubMed ID: 1337507
    [Abstract] [Full Text] [Related]

  • 39. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [Abstract] [Full Text] [Related]

  • 40. Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates.
    Sato K, Hoshino K, Tanaka M, Hayakawa I, Osada Y.
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1491-8. PubMed ID: 1324647
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.